Multicenter Investigation of Limitation of Infarct Size (MILIS)
Status:
Completed
Trial end date:
1985-12-01
Target enrollment:
Participant gender:
Summary
To assess the ability of two separate therapeutic interventions, propranolol and
hyaluronidase, to limit the ultimate size of an acute myocardial infarction. A secondary
objective was to assess the influence of these therapies upon ventricular function and
morbidity following myocardial infarction.